Armodafinil and modafinil – May 2022

• Brand name:
  • Various brands
• Pharmaceutical Company:
  • Australasian Sleep Association
• Condition/Indication: Narcolepsy
• Meeting Date: May 2022
• Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 423KB)
• Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 47KB)

Related Public Summary Documents

• Armodafinil and modafinil – July 2020